{
    "913": "a Gram positive, anaerobic bacterium",
    "914": "Spo0A",
    "915": "Spo0A",
    "916": "clostridial toxins A and B",
    "5287": "kobuvirus and rotavirus shedding in suckling piglets",
    "5288": "19.2 to 103.5X",
    "5289": "lower than 7",
    "5290": "653 nt",
    "5291": "Strain 17V079",
    "2988": "enteric cytopathic human orphan virus",
    "2989": "respiratory illness, hand-foot-and-mouth disease",
    "2990": "California Department of Public Health",
    "2991": "within 1 day of identification of etiology",
    "2992": "CDPH",
    "2993": "E-30",
    "2994": "260-fold",
    "2995": "one structural (P1-capsid) and two nonstructural",
    "5262": "to investigate the different pathogens involved in ILI and describe the associated symptoms",
    "5263": "Réseau Sentinelles",
    "5264": "occurrence of a sudden fever above 39uC with myalgia and respiratory signs",
    "5265": "rhinovirus",
    "430": "nine",
    "431": "double-stranded",
    "432": "VP1-VP4, VP6 and VP7",
    "433": "NSP1-NSP5/NSP6",
    "434": "Qualitative Real-Time Polymerase Chain Reaction",
    "4051": "FIP virus",
    "4052": "nonsegmented, positive sense, single-stranded RNA genome",
    "4053": "shedding in their faeces",
    "4055": "attenuated, temperature-sensitive strain of type II FIPV",
    "4056": "safety and efficacy",
    "4057": "30 minutes",
    "4058": "using a nano Isothermal Titration Calorimeter",
    "5277": "antiproliferative effect",
    "5278": "colorectal cancer",
    "5279": "83.2% and 64.3%,",
    "5280": "64.3%,",
    "5281": "detection of nuclear condensation",
    "5282": "apoptotic chromatin changes",
    "5283": "nuclear",
    "5284": "HT-29 cells",
    "1149": "pneumonia",
    "1151": "pharyngeal (Ct = 30 + 30) and blood samples",
    "1160": "positively correlated with the severe disease stage",
    "1168": "mild or severe clinical symptom groups",
    "1169": "positively correlated",
    "1171": "viral RNA",
    "1170": "positively correlated",
    "1172": "replicate in the digestive tract",
    "1173": "unavailability of convincingly scientific evidence",
    "1174": "rampant coronavirus replication",
    "5271": "arenavirus and bunyavirus",
    "5272": "phylogenetically independent",
    "5273": "1-3 weeks",
    "5274": "one genus",
    "5275": "four known proteins",
    "5276": "PCR assays",
    "601": "fecal–oral contact",
    "602": "antigen delivery",
    "603": "intestine epithelial cells",
    "604": "mucosal",
    "605": "physical, chemical, and biological barriers",
    "606": "nonpathogenic Gram-positive bacterium",
    "607": "maintenance of gut homeostasis",
    "608": "gut-associated lymphoid tissue",
    "609": "\nPPs",
    "610": "Intestinal IELs",
    "611": "serum IgG and mucosal SIgA",
    "612": "cytokines",
    "613": "IL-1β",
    "3593": "bat beta-coronaviruses",
    "3589": "more than 1,000",
    "3590": "a recombinant CoV",
    "3592": "∼80%",
    "3594": "99.8% homology",
    "3595": "greater than 1,100 nt differences",
    "3596": "which are distributed throughout the genome",
    "3597": "The absence of a logical targeted pattern",
    "3598": "the construction of a chimeric CoV with a bat CoV S gene",
    "3599": "significant divergence in the genetic sequence of this construct",
    "3600": "by serial passage of an infectious wildtype SARS CoV clone",
    "3601": "After 15 passages in mice",
    "3602": "due to the mouse adaptation",
    "3604": "unable to use human ACE2 as a receptor for entry into human cells",
    "3605": "several novel bat coronaviruses were isolated from Chinese horseshoe bats",
    "3606": "an intermediate host may not be necessary",
    "3607": "it was proposed",
    "3608": "SL-SHC014-MA15 virus",
    "3609": "elevated pathogenic activity of the SHC014-MA15 chimeric virus",
    "3610": ">6,000 nucleotide differences across the whole genome",
    "3611": "artificially, or intentionally",
    "3612": "they used careful bioinformatics analyses",
    "3613": "withdrawn this report",
    "3614": "stepwise and accrues mutations gradually over time",
    "3615": "an intermediate host may not be necessary",
    "3616": "an intermediate host may not be necessary",
    "4574": "severe acute respiratory syndrome (SARS) caused by SARS-CoV",
    "4070": "to evaluate the anti-influenza A virus",
    "4071": "NA glycoproteins of influenza A and B virus",
    "4072": "cleave the α-ketosidic linkage between terminal",
    "4073": "oseltamivir",
    "4074": "CC 50",
    "4075": "MTT method",
    "4076": "the function of NA protein may be suppressed by patchouli alcohol",
    "314": "Protease inhibitor",
    "315": "Rupintrivir was well tolerated and reduced viral loads and respiratory symptoms",
    "308": "viral",
    "309": "respiratory syncytial virus",
    "310": "human rhinovirus",
    "311": "human rhinovirus",
    "313": "chronic airway inflammation, and a history of respiratory symptoms",
    "317": "morbid obesity",
    "319": "two",
    "320": "HA) and the neuraminidase (NA)",
    "322": "oseltamivir",
    "323": "H275Y",
    "324": "difficulty with aerosol delivery, cost and potential harm to healthcare workers",
    "2167": "acellular",
    "2168": "Southeast Asia",
    "2169": "whole cell",
    "2170": "cough, difficulty breathing, and cough with vomit",
    "2171": "nasal",
    "2173": "every 2 to 4 years",
    "2174": "2 weeks of cough, whoop, or posttussive vomiting",
    "5160": "infectious bronchitis virus",
    "5161": "uninfected and infected",
    "5162": "spleen",
    "1658": "HCoV",
    "1659": "HCoV-OC43",
    "1660": "HCoV",
    "1717": "Highly virulent species of HCoV",
    "1718": "14% to 45%.",
    "1719": "HCoV-OC43 and HCoV-229E",
    "1720": "HCoV species",
    "5252": "Two hundred",
    "5253": "600,000",
    "5254": "conflicting results",
    "3692": "we analyzed a 2019-nCoV complete genome",
    "3693": "89% nucleotide identity",
    "3694": "82%",
    "3695": "unique genomic features",
    "3696": "animal source of 2019-nCoV and its more ancestral virus",
    "3697": "enveloped, positive-sense, single-stranded RNA viruses",
    "3698": "CoVs",
    "3699": "gene sources of most αCoVs and βCoVs",
    "3700": "severe acute respiratory syndrome CoV (SARS-CoV)",
    "3701": "bats",
    "3702": "6",
    "3703": "self-limiting upper respiratory infections",
    "3704": "may cause severe lower respiratory tract infection",
    "3705": "a familial cluster of 2019-nCoV infection",
    "3706": "a 2019-nCoV complete genome",
    "3707": "2019-nCoV HKU-SZ-005b",
    "3708": "human, bats, and Himalayan palm civet",
    "3709": "using MEGA X software",
    "3710": "using the Poisson correction method",
    "3711": "using PSI-blast-based secondary structure PREDiction",
    "3712": "initial amino acid sequences were input and analysed using neural networking and its own algorithm",
    "3713": "The single-stranded RNA genome",
    "3714": "38%.",
    "3715": "more similar",
    "3716": "orf3b, Spike and orf8",
    "3717": "a signal peptide",
    "3718": "conserved fusion peptide (FP),",
    "3719": "broad spectrum antiviral peptides",
    "3720": "similar",
    "3721": "external subdomain",
    "3722": "external subdomain",
    "3723": "its receptor usage, interspecies transmission and pathogenesis",
    "3724": "two stretches of deletions in the spike receptor binding domain (RBD)",
    "3726": "Yunnan strains such as the WIV1",
    "3727": "can use human ACE2 as a cellular entry receptor",
    "3728": "suckling rats",
    "3729": "The two retained deletion sites in the Spike genes",
    "3730": "different orf3b proteins display different IFN antagonist activities",
    "3731": "an accessory protein",
    "3732": "fulllength",
    "3733": "two bat SARS-related-CoV",
    "3734": "Betacoronavirus lineage B coronaviruses",
    "3735": "distant",
    "3736": "split of full length",
    "3737": "to form a protein with an alpha-helix",
    "3738": "2019-nCoV is a novel lineage",
    "1238": "Public Health Emergency of International Concern",
    "1239": "an extraordinary event which is determined to constitute a public health risk to other States",
    "1240": "Global Initiative on Sharing All Influenza Data",
    "5226": "Methicillin-resistant Staphylococcus aureus",
    "5227": "vancomycin therapy",
    "5228": "isocitrate lyase",
    "5229": "to determine the potential bactericidal role of novel antibacterial compounds",
    "887": "TNF-α",
    "888": "TNF-α",
    "889": "MAPK phosphatase-1",
    "890": "Mycobacterium tuberculosis",
    "891": "one third",
    "892": "9.2 million",
    "893": "p38 MAPK and ERK1/2",
    "894": "by phosphorylation",
    "895": "MAPKs",
    "896": "at least 10",
    "897": "a cell wall component of Gram-negative bacteria",
    "898": "a Gram positive bacteria",
    "899": "MAPK"
}